Redeye states that Q2 came in below estimates and that much needs to happen on the growth side to re...
Redeye has a positive view of the new distribution agreement for Carbonhand in Switzerland.
Redeye is uplifted by Enea's new large order for mobile-messaging security.
Redeye gives a short comment on Remedy’s H1 2022 report.
Solteq reported weak Q2 figures, mainly due to challenges in the Utilities business.
Report fairly in line with expectations Healthy pipeline of projects and stabilization in cost infl...
Redeye updates its view on Thunderful after the Q2’22 report.
Redeye updates estimates and valuation following G5’s Q2-results which came in weaker than expected,...
Rovio's Q2 revenue was 5% below Infront consensus, whereas adjusted EBIT was in line.
Relais issued a profit warning on 8 August, flagging weak profitability in H1.
After revisiting the Freja case following the Q2 report, we conclude: 1) Freja’s niche Org eID marke...
Sales in line, but profitability and outlook worse ‘22e, ‘23e & ‘24e adj.
Redeye comments on Evaxion’s second quarter report 2022.
Redeye embraces the new GARDskin order of approximately SEK 1m.
100% organisk tillväxt i Q1 Candles meddelade i går att den organiska tillväxten för Q1 22/23 når ca...
Relais reported Q2 headline figures in line with its pre-release that was given in conjunction with ...
Redeye retains its positive view on Transtema following a strong Q2 report.
Rovio’s Q2 revenue of EUR 78.4m came in 5% below consensus and 4% below our estimate whereas adjuste...
Redeye comments on Freemelt’s Q2 results, which came in lower than expected, primarily due to a deli...
Redeye states that the Q2 report was strong on all fronts.
